The field of pharmacology has witnessed significant advancements in the treatment of endocrine disorders. Among the newer medications, Mounjaro and Ozempic have gained attention due to their efficacy in managing conditions such as type 2 diabetes and obesity. Discuss about similarities, differences, and clinical implications of these two new drugs.
Ding, Y.,
Shi, Y., Guan, R., et al. (2023). Evaluation and comparison of efficacy and
safety of tirzepatide and semaglutide in patients with type 2 diabetes
mellitus: A Bayesian network meta-analysis. Pharmacological Research, 107,
Article 107031. https://doi.org/10.1016/j.phrs.2023.107031
Frías, J.
P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus
semaglutide once weekly in patients with type 2 diabetes. The New England
Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
Karagiannis,
T., Malandris, K., Avgerinos, I., et al. (2024). Subcutaneously administered
tirzepatide vs semaglutide for adults with type 2 diabetes: A systematic review
and network meta-analysis of randomised controlled trials. Diabetologia, 67(7),
1206–1222. https://doi.org/10.1007/s00125-024-06144-1